James Richard Reis Net Worth

The estimated Net Worth of James Richard Reis is at least $143 Mille dollars as of 1 October 2015. James Reis owns over 20,000 units of Arcadia Biosciences Inc stock worth over $143,000 and over the last 10 years James sold RKDA stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

James Reis RKDA stock SEC Form 4 insiders trading

James has made over 5 trades of the Arcadia Biosciences Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently James exercised 20,000 units of RKDA stock worth $44,800 on 1 October 2015.

The largest trade James's ever made was exercising 20,000 units of Arcadia Biosciences Inc stock on 1 October 2015 worth over $44,800. On average, James trades about 14,583 units every 22 days since 2015. As of 1 October 2015 James still owns at least 50,000 units of Arcadia Biosciences Inc stock.

You can see the complete history of James Reis stock trades at the bottom of the page.

What's James Reis's mailing address?

James's mailing address filed with the SEC is 202 Cousteau Pl, Davis, CA 95618, USA.

Insiders trading at Arcadia Biosciences Inc

Over the last 9 years, insiders at Arcadia Biosciences Inc have traded over $35,492 worth of Arcadia Biosciences Inc stock and bought 2,813,834 units worth $22,335,794 . The most active insiders traders include Terri Csperling Peter V Mor..., Darby E Shupp e Albert D. Bolles. On average, Arcadia Biosciences Inc executives and independent directors trade stock every 49 days with the average trade being worth of $147,899. The most recent stock trade was executed by Mark Kawakami on 1 August 2024, trading 700 units of RKDA stock currently worth $1,442.

What does Arcadia Biosciences Inc do?

arcadia biosciences (nasdaq: rkda) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. arcadia’s goodwheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. the company’s portfolio of agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. for more information visit www.arcadiabio.com.

Complete history of James Reis stock trades at Arcadia Biosciences Inc

Arcadia Biosciences Inc executives and stock owners

Arcadia Biosciences Inc executives and other stock owners filed with the SEC include:

• Pamela Haley,
  CFO & Corp. Sec.
• Laura Pitlik,
  Chief Marketing Officer
• Kevin J. Comcowich,
  Chairman & Interim CEO
• Amy Yoder,
  Director
• Gregory Waller,
  Director
• Lilian Shackleford Murray,
  Director
• Peter Gajdos,
  Director
• Albert Bolles,
  Director
• Jamie Bechtel,
  Director
• Sarah Reiter,
  Chief Commercial Officer
• Zhongjin Lu,
  Director - Product Development
• Kevin Hodges,
  Vice President - Commercial Operations
• Donald Emlay,
  Vice President - Regulatory Affairs and Compliance
• Tracy Baker,
  Vice President - Product Innovation
• Pamela Haley,
  Chief Financial Officer
• Matthew Plavan,
  Chief Executive Officer, Director
• Kevin Comcowich,
  Chairman of the Board
• Stanley E. Jacot Jr.,
  Pres, CEO & Director
• Stan Jacot,
  Pres & CEO
• Dr. Zhongjin Lu Ph.D.,
  Director of Product Devel.
• Brian Schaffer,
  Sr. VP of Sales
• Belinda Yao,
  VP of Operations
• George Frederick John Gosbee,
  Director
• Darby E Shupp,
  Director
• Rajiv Shah,
  Director
• Wendy S. Neal,
  VP, Chief Legal Officer
• James Richard Reis,
  Director
• Uday Garg,
  Director
• Matthew A. Ankrum,
  Director
• Steven F. Brandwein,
  VP Finance and Administration
• Roger Salameh,
  VP Business Development
• Mark Wong,
  Director
• Vic C. Knauf,
  Chief Scientific Officer
• Eric J. Rey,
  President and CEO
• Don Emlay,
  VP Regulatory and Compliance
• Agribusiness Co Investments...,
  
• Terri Csperling Peter V Mor...,
  
• Randall Shultz,
  Chief Technology Officer
• Chris Cuvelier,
  Chief Growth Officer
• Laura Pitlik,
  Chief Marketing Officer
• Stanley Jr Jacot,
  Chief Executive Officer
• Deborah D Carosella,
  
• Thomas J. Schaefer,
  Chief Executive Officer
• Mark Kawakami,
  Chief Financial Officer